Home LiteratureArticle Details
PMID: 959087 Published · ppublish English Journal Article

Therapy of the hyperlipidemias.

Postgraduate medicine ·Vol. 60 ·No. 3 ·1976-09-00 ·Pages 99-107

Lees RS, Lees AM

Abstract

Although the diagnosis of hyperlipidemia is somewhat arbitrary, in that the upper limits of normal are not universally agreed upon, it is clear that the risk of atherosclerosis increases with plasma cholesterol concentration; it may also increase in hyperglyceridemia. We take 220 mg/100 ml as the upper limit of normal for plasma cholesterol and 140 mg/100 ml as the upper limit for triglycerides. Treatment of hyperlipidemia is aimed at reducing the risk of atherosclerosis or arresting its course. Alteration of diet is the first step. If maximal diet therapy does not lower plasma lipids to acceptable levels, drug therapy is added. The decision to treat hyperlipidemia with drugs should be based on a careful weighing of risk vs. benefit for each patient. Because of the rapid change in our knowledge of both the risks and the benefits of therapy, that decision must be reviewed and updated at regular intervals.

MeSH Terms
Anticoagulants/therapeutic use Blood Platelets/drug effects Child Cholesterol/blood Chylomicrons/blood Clofibrate/adverse effects,therapeutic use Diet, Reducing Drug Therapy, Combination Female Humans Hypercholesterolemia/classification Hyperlipidemias/diagnosis,diet therapy,drug therapy Lipoproteins/blood Male Nicotinic Acids/therapeutic use Norethindrone/therapeutic use Oxandrolone/therapeutic use Phenotype Triglycerides/blood
Chemicals
Anticoagulants Chylomicrons Lipoproteins Nicotinic Acids Triglycerides Oxandrolone Cholesterol Clofibrate Norethindrone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lees R S
Lees A M
Article Info
Journal
Postgraduate medicine
Abbr.
Postgrad Med
ISSN
0032-5481
Published
1976-09-00
Pages
99-107
Language
English
Region
England
NLM ID
0401147
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com